Position in AXGN
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$1,869,857
+$46,895 QoQ
Shares Held
56,440
+1.3% QoQ
Ownership
0.106%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 20.038979447200568.ToString("F0")%
Shared 0.ToString("F0")%
None 79.96102055279944.ToString("F0")%
Common Shares in AXGN Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026RHUMBLINE ADVISERS holds $1,402,735,885 across 83 Medical Devices names. AXGN ranks #32 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
2,876,810 | $295,362,082 | |
| 2 | SYK |
Stryker Corp
|
633,935 | $208,304,701 | |
| 3 | MDT |
Medtronic plc
|
2,241,292 | $194,207,951 | |
| 4 | BSX |
Boston Scientific Corp
|
2,674,641 | $167,833,722 | |
| 5 | EW |
Edwards Lifesciences Corp
|
1,067,753 | $85,505,660 | |
| 6 | GEHC |
GE HealthCare Technologies Inc.
|
763,138 | $54,320,162 | |
| 7 | DXCM |
Dexcom Inc
|
772,557 | $48,516,579 | |
| 8 | STE |
STERIS plc
|
214,808 | $47,500,493 |
All Filings in AXGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,869,857 | 56,440 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $1,822,962 | 55,697 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,157,584 | 64,887 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $703,655 | 64,853 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,114,884 | 60,264 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $959,663 | 58,232 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $795,088 | 56,711 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $421,056 | 58,157 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $442,050 | 54,777 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $362,857 | 53,127 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $273,530 | 54,706 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $496,480 | 54,379 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $499,451 | 52,852 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $534,069 | 53,514 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $623,416 | 52,300 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $397,698 | 48,559 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $327,715 | 41,274 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $382,867 | 40,861 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $668,766 | 42,327 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $877,668 | 40,614 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $880,560 | 43,463 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $822,916 | 45,973 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $508,498 | 43,723 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $461,796 | 49,978 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $479,700 | 46,125 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||